Insulin used to be the poster child for drug prices that punished the uninsured, with cash payers spending over $200 a month on average as recently as 2018. That has genuinely changed. After 2023 list-price cuts of 65% to 78% across the major brands and the rollout of $35 monthly savings programs, federal ASPE data shows average out-of-pocket costs for cash and assistance-program payers fell to about $70.93 a month by 2025, and most people can do better than that.
The catch is that the lowest prices are not automatic. The $35 cap for uninsured and commercially insured patients comes from voluntary manufacturer programs you must enroll in, and pharmacies will happily charge you the higher retail price if you show up without a card. This guide covers what insulin actually costs in cash in 2026, every $35 program and how to enroll, and the Walmart option that requires no paperwork at all.
What Does Insulin Cost Without Insurance?
Here is the landscape for a 30-day supply, combining manufacturer program pricing with GoodRx retail data pulled in August 2026 and Walmart’s published ReliOn prices.
| Option | Low | Typical | High |
|---|---|---|---|
| Any Lilly, Novo Nordisk, or Sanofi insulin with a $35 program card (30-day supply) | $35 | $35 | $55 (Novo’s Awiqli only) |
| Walmart ReliOn Novolin R or N (human insulin, per vial) | ~$25 | ~$25 | ~$25 |
| Walmart ReliOn NovoLog (analog, no card needed) | $72.88 (vial) | $85.88 (5 FlexPens) | $85.88 |
| Generic insulin lispro, cash with coupon (per vial) | $30.53 | $68.33 (avg retail) | $137.11 (brand Humalog vial retail) |
| Lantus, cash with coupon | $35.00 | $93.93 (vial retail) | $324.89 (avg retail, most common version) |
| Average cash-payer monthly out-of-pocket (ASPE, 2025) | - | $70.93 | - |
Two things jump out. First, the $35 programs beat almost every other route, and they cover a full month of insulin regardless of how many vials or pens that takes (within program limits). Second, retail prices without any card are still meaningfully higher, so the difference between walking in with a program card and without one can be $100 to $300 per fill.
Prices vary by pharmacy and region, so treat the retail figures as national averages. The program prices do not vary: $35 is $35 at any participating pharmacy.
The $35 Manufacturer Programs, Brand by Brand
Nearly every insulin sold in the US comes from three companies, and all three now offer $35 monthly pricing that uninsured patients can use. You need a valid prescription for all of them, and none of them are insurance.
Lilly Insulin Value Program
Covers all Lilly insulins, including Humalog, Insulin Lispro, Basaglar, Rezvoglar, Lyumjev, and Humulin, at $35 per monthly prescription whether you have commercial insurance or no insurance. Uninsured patients can use it for up to 14 fills per year per insulin. People on Medicare, Medicaid, or other government programs are excluded, though Medicare’s own $35 Part D cap covers that group. Download the savings card at insulins.lilly.com and show it at the pharmacy. Lilly also sells its non-branded insulin lispro at a $25 per vial list price, per the HHS ASPE report.
Novo Nordisk MyInsulinRx
A cash offer of $35 for a 30-day supply, defined as up to 3 vials or 2 packs of pens, of any combination of Novo Nordisk insulins, including NovoLog, NovoLog Mix 70/30, Fiasp, Tresiba, Novolin R, Novolin N, and Novolin 70/30. The once-weekly insulin Awiqli is offered at $55 per month, and needles cost $25 per pack. Enroll online at novocare.com, by texting ENROLL to 24177, or by calling 1-888-910-0454. Re-enrollment is required each calendar year.
Sanofi Insulins Valyou Savings Program
As of January 1, 2026, Sanofi offers a 30-day supply of any combination, type, and quantity of its insulins, including Lantus and Toujeo, for $35 to all US patients with a valid prescription, regardless of insurance status, income, or whether you are on Medicare or commercial coverage. Enroll through Sanofi Patient Connection or call 1-888-847-4877. Sanofi says the card works at most US pharmacies, including independents.
One caveat that applies to all three: program payments generally do not count toward an insurance deductible or out-of-pocket maximum. If you have coverage and are close to meeting your deductible, run the math both ways.
Walmart ReliOn: No Card, No Enrollment
If enrolling in a program is a barrier, Walmart’s private-label ReliOn line has flat everyday prices. ReliOn Novolin R (regular) and Novolin N (NPH) human insulins cost about $25 per vial. ReliOn NovoLog, a private-brand version of the analog insulin aspart made by Novo Nordisk, costs $72.88 per vial or $85.88 for a box of five FlexPens at Walmart and Sam’s Club pharmacies, which Walmart says is 58% to 75% below branded analog cash prices.
Two warnings. ReliOn NovoLog requires a prescription, and while older human insulins like Novolin R and N are cheaper and available without a prescription in many states, they act on a different timing curve than modern analogs. Never switch insulin types on price alone; have the prescriber who manages your diabetes adjust the plan. That is cost navigation advice, not medical advice: the point is that a $25 vial only saves money if it is a clinically appropriate substitution.
What Drives the Price
Whether you enroll in a program. The single biggest factor. The same vial can cost $35 with a card and $100 to $300 without one.
Brand vs. generic and biosimilar. Generic insulin lispro averages $68.33 per vial against $137.11 for brand Humalog. Biosimilars of Lantus (Rezvoglar, Semglee) typically price below the original.
Vials vs. pens. Pens cost more per unit of insulin. Humalog kwikpen cartons retail around $212 to $234 versus $137 for a vial. The $35 programs flatten this difference, which is a reason to use them if you prefer pens.
How much insulin you use. Higher daily doses mean more vials or pens per month. The Novo and Sanofi programs price a 30-day supply as a combination quantity, which protects high-dose users.
Pharmacy choice. Cash and coupon prices vary between chains for the identical product, so compare before you fill. Our GoodRx vs. SingleCare comparison covers how to shop discount cards.
Cash Price vs. Insurance
With the manufacturer programs open to uninsured patients, cash payers are no longer at an automatic disadvantage on insulin. ASPE data shows average monthly out-of-pocket costs of $18.26 for commercially insured patients and $12.04 for Medicare in 2025, so insurance is still cheaper on average, but the $35 program price is fixed, predictable, and often below what a high-deductible plan charges before the deductible is met.
If you have commercial insurance, you can still use these programs; Lilly’s version allows up to 16 fills per year for insured patients. If your plan’s copay is above $35, the program card wins. If you are on Medicare Part D, federal law already caps each insulin at $35 per month, so you do not need the manufacturer card.
Also remember that insulin is only part of the cost of managing diabetes without coverage. Budget for office visits and periodic lab work like A1C testing, both of which have workable cash options.
How to Pay Less
1. Enroll in your manufacturer’s $35 program today. It is free, takes minutes, and covers a month of insulin at $35: Lilly at insulins.lilly.com, Novo Nordisk at novocare.com or 1-888-910-0454, Sanofi through Sanofi Patient Connection or 1-888-847-4877. Re-enroll each January.
2. Apply for free insulin if your income qualifies. All three manufacturers run patient assistance programs that provide insulin at no cost to uninsured patients meeting income requirements. If you need help applying, free clinics and community health centers routinely walk patients through these applications and offer sliding-scale diabetes care.
3. Use ReliOn if you shop at Walmart anyway. About $25 per vial for human insulin, $72.88 for analog ReliOn NovoLog, no enrollment needed.
4. Ask your prescriber about lower-cost equivalents. Non-branded insulin lispro ($25 list per vial from Lilly), insulin aspart, and glargine biosimilars like Rezvoglar deliver the same molecules as Humalog, NovoLog, and Lantus at lower list prices.
5. Compare coupon prices when a program does not apply. GoodRx shows Lantus as low as $35 and insulin lispro as low as $30.53 with coupons. See GoodRx vs. SingleCare for how to squeeze the most from discount cards.
6. Buy a 90-day supply only after checking program rules. The $35 programs price per 30-day fill, so three monthly fills cost $105 predictably, which may beat a 90-day cash price. Count your allowed fills per year (14 for uninsured patients on Lilly’s program) when planning.
The Bottom Line
If you are paying more than $35 a month for insulin without insurance in 2026, you are almost certainly missing a program you qualify for. Enroll with your insulin’s manufacturer, keep the card with your prescription info, and re-enroll every calendar year. Use ReliOn pricing as a no-paperwork fallback, patient assistance programs if your income qualifies you for free insulin, and discount coupons for anything the programs do not cover. The days of $300 vials are not fully gone, but they are now optional. For strategies on other recurring prescriptions, see our guides to EpiPen costs and GLP-1 costs without insurance.